Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Asia Pac J Public Health ; 33(8): 951-952, 2021 11.
Article in English | MEDLINE | ID: mdl-33771052

ABSTRACT

Although coronavirus vaccine roll-out is beginning, standard public health practices will, for most people, remain their first line of protection for some time. Three principles guiding the pandemic control process, namely community participation, promotion of equity, and cultural sensitivity, can help people adhere to public health advice. These three principles can enhance intervention effectiveness, decreasing the rate of infection and protecting human rights, promoting social harmony and preventing unrest.


Subject(s)
COVID-19 , Pandemics , COVID-19 Vaccines , Community Participation , Humans , Pandemics/prevention & control , Public Health , SARS-CoV-2
2.
PLoS One ; 16(2): e0247911, 2021.
Article in English | MEDLINE | ID: mdl-33635928

ABSTRACT

Despite most Indonesian women now receiving antenatal care on the nationally recommended four occasions and being delivered by skilled birth attendants, the nation's maternal mortality ratio (MMR) is estimated as 177 per 100,000 live births. Recent research in a rural district of Indonesia has indicated that poor service quality due to organizational and personnel factors is now a major determinant of this high MMR. The present research is an in-depth analysis of possible health service organizational and quality of care related causes of death among 30 women admitted to a peak referral hospital in a major Indonesian city. Despite their condition being complex or deteriorating, most of these women arrived at the hospital in a state where it was feasible to prevent death with good quality care. Poor application of protocols, poor information flow from frontline hospitals to the peak referral hospital, delays in emergency care, and delays in management of deteriorating patients were the main contributing factors to these deaths. Pyramidal referrals also contributed, as many women were initially referred to hospitals where their condition could not be effectively managed. While generic quality improvement measures, particularly training and monitoring for rigorous application of clinical protocols (including forward planning for deteriorating patients) will help improve the situation, the districts and hospitals need to develop capacity to assess their local situation. Unless local organisational factors, staff knowledge and skill, blood and blood product availability, and local reasons for delays in providing care are identified, it may not be possible to effectively reduce the adverse pregnancy outcomes.


Subject(s)
Eclampsia/mortality , Postpartum Hemorrhage/mortality , Pre-Eclampsia/mortality , Pregnancy Complications, Infectious/mortality , Prenatal Care/organization & administration , Quality of Health Care , Cities , Eclampsia/epidemiology , Female , Health Knowledge, Attitudes, Practice , Health Personnel/psychology , Health Services Accessibility/organization & administration , Humans , Indonesia , Maternal Mortality , Postpartum Hemorrhage/epidemiology , Pre-Eclampsia/epidemiology , Pregnancy , Pregnancy Complications, Infectious/epidemiology , Referral and Consultation , Risk Factors , Time-to-Treatment
3.
Expert Rev Pharmacoecon Outcomes Res ; 18(1): 71-81, 2018 Feb.
Article in English | MEDLINE | ID: mdl-28800399

ABSTRACT

INTRODUCTION: Australia, England, France and New Zealand use different policies to regulate their medicines market, which can impact on utilisation and price. OBJECTIVES: To compare the prices and utilisation of statins in Australia, England, France and New Zealand from 2011 to 2013. METHODS: Utilisation of statins in the four countries was compared using Defined Daily Doses (DDD) per 1000 inhabitants per year. Pairwise Laspeyres and Paasche index comparisons were conducted comparing the price and utilisation of statins. RESULTS: The results showed that the price of statins in New Zealand was the cheapest. The price of statins in Australia was most expensive in 2011 and 2012 but France was more expensive in 2013. There were large differences between the Laspeyres index and Paasche index when comparing the price and utilisation of England with Australia and France. DISCUSSION: The policies that regulate the New Zealand and England medicines markets were more effective in reducing the price of expensive statins. The relative utilisation of cheaper statins was greatest in England and had a large effect on the differences between the two index results. The pricing policies in Australia have been only partly effective in reducing the price of statins compared to other countries.


Subject(s)
Drug Costs/statistics & numerical data , Drug and Narcotic Control/legislation & jurisprudence , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Commerce/statistics & numerical data , Cost Control , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/economics
SELECTION OF CITATIONS
SEARCH DETAIL
...